Title: A risk prediction model for nausea and vomiting after TACE : a cross-sectional study
Version: 1 Date: 29 Oct 2024
Reviewer's report:
The study investigated the factors associated with nausea and vomiting after TACE and
developed a predictive model to predict these adverse events. Though interesting, unfortunately,
nausea and vomiting after TACE is not an important end point for HCC patients. Nausea and
vomiting could be affected by tumor size, use of chemotherapy drugs and dosages of drugs, use
of DC bead and use of anti-emetic, prior history of vomiting after C/T. These factors are familiar
for most hepatologists  who ever cared of TACE p'ts.  The so-called post-TACE syndrome has
been shown to be reduced by use of steroid.  Thus, the current study adds little value for the
care of TACE p'ts.
Title: A risk prediction model for nausea and vomiting after TACE : a cross-sectional study
Version: 1 Date: 29 Oct 2024
Reviewer's report:
The study investigated the factors associated with nausea and vomiting after TACE and
developed a predictive model to predict these adverse events. Though interesting, unfortunately,
nausea and vomiting after TACE is not an important end point for HCC patients. Nausea and
vomiting could be affected by tumor size, use of chemotherapy drugs and dosages of drugs, use
of DC bead and use of anti-emetic, prior history of vomiting after C/T. These factors are familiar
for most hepatologists  who ever cared of TACE p'ts.  The so-called post-TACE syndrome has
been shown to be reduced by use of steroid.  Thus, the current study adds little value for the
care of TACE p'ts.
Please review this paper.
user
Title: A risk prediction model for nausea and vomiting after TACE : a cross-sectional study
Version: 1 Date: 29 Oct 2024
Reviewer's report:
The study investigated the factors associated with nausea and vomiting after TACE and
developed a predictive model to predict these adverse events. Though interesting, unfortunately,
nausea and vomiting after TACE is not an important end point for HCC patients. Nausea and
vomiting could be affected by tumor size, use of chemotherapy drugs and dosages of drugs, use
of DC bead and use of anti-emetic, prior history of vomiting after C/T. These factors are familiar
for most hepatologists  who ever cared of TACE p'ts.  The so-called post-TACE syndrome has
been shown to be reduced by use of steroid.  Thus, the current study adds little value for the
care of TACE p'ts.
assistant